Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Biochemistry|January 31, 1998
A novel dCMP methylase by engineering thymidylate synthaseS Agarwalla, S LaPorte, L Liu, et al.
La Revue De Medecine Interne|January 1, 1994
[Aging and procedural memory. Study of a series of tests on microcomputers]C Thomas-Antérion, A Marion, B Laurent, et al.
Clinical Biomechanics (Bristol, Avon)|February 12, 2022
Société de Biomécanique Young Investigator Award 2021: Numerical investigation of the time-dependent stress-strain mechanical behaviour of skeletal muscle tissue in the context of pressure ulcer preventionT Lavigne, G Sciumè, S Laporte, et al.
Pharmacopsychiatry|July 24, 2012
Antipsychotics: a real or confounding risk factor for venous thromboembolism?C Chapelle, S Quenet, X Delavenne, et al.
Computer Methods in Biomechanics and Biomedical Engineering|August 2, 2006
3D reconstruction of the pelvis from bi-planar radiographyD Mitton, S Deschênes, S Laporte, et al.
British Journal of Clinical Pharmacology|May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldA Berges, S Laporte, M Epinat, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapyP Girard, M Decousus, S Laporte, et al.
Annales De Chirurgie|April 6, 2002
[Laparoscopic re-establishment of digestive continuity following Hartmann's procedure. Retrospective study of the French Society of Endoscopic Surgery]C Vacher, R Zaghloul, F Borie, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancerG Simonneau, S Laporte, P Mismetti, et al.
Thrombosis and Haemostasis|February 11, 2000
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trialsP Mismetti, S Laporte-Simitsidis, B Tardy, et al.
Pageof 10